Prevention of Morbidity in Sickle Cell Disease - 2a: Pilot phase

• Research type

  Research Study

• Full title

  Prevention of Morbidity in Sickle Cell Disease 2a - pilot phase. (POMS 2a) Improvement of Pain and Quality of Life in Patients with Sickle Cell Disease with Nocturnal Oxygen Therapy or Auto-adjusting Continuous Positive Pressure: pilot phase

• IRAS ID

  147642

• Contact name

  Fenella Kirkham

• Contact email

  Fenella.Kirkham@uhs.nhs.uk

• Sponsor organisation

  University Hospital Southampton

• REC name

  East of England - Cambridge South Research Ethics Committee

• REC reference

  14/EE/0163

• Date of REC Opinion

  3 Jun 2014

• REC opinion

  Further Information Favourable Opinion